Ophthalmological abnormalities in children with congenital disorders of glycosylation type I
E Morava1, H N Wosik, J Sykut-Cegielska
1Radboud University Nijmegen Medical Centre, Department of Pediatrics, PO Box 9101, 6500 HB Nijmegen, The Netherlands. E.Morava@cukz.umcn.nl
Insights
Ophthalmological abnormalities are common in children with Congenital Disorders of Glycosylation (CDG), affecting vision and eye structures. Early screening for these eye conditions in all CDG patients is recommended.
Area of Science:
- Ophthalmology
- Genetics
- Pediatrics
Background:
- Congenital Disorders of Glycosylation (CDG) type Ia often present with ocular issues and vision loss.
- Limited information exists regarding ophthalmological abnormalities in other CDG subtypes.
Purpose of the Study:
- To investigate the prevalence and spectrum of ocular abnormalities in children with CDG type I.
- To compare ophthalmic findings across different CDG subgroups.
Main Methods:
- Evaluated 45 children diagnosed with CDG type I for ocular abnormalities at diagnosis and during follow-up.
- Compared ophthalmic findings among CDG type Ia, Ic, and undiagnosed (Ix) subgroups.
Main Results:
- Ocular anomalies were found in 28 out of 45 children.
- Unique findings included congenital cataract, retinal coloboma, and glaucoma.
- CDG type Ia patients exhibited sequential symptoms like retinitis pigmentosa and cataract.
Conclusions:
- Ophthalmic findings are frequent in CDG syndrome, affecting both anterior and posterior eye segments.
- CDG can lead to abnormal eye development, vision impairment, motility issues, and altered intraocular pressure.
- Routine ophthalmological screening and follow-up are suggested for all children diagnosed with CDG.
Background:
Children with congenital disorders of glycosylation (CDG) type Ia frequently present with ocular involvement and visual loss. Little is known, however, about the occurrence of ophthalmological abnormalities in other subtypes of CDG syndrome.
Methods:
We evaluated 45 children sequentially diagnosed with CDG type I for the presence of ocular abnormalities at the time of the diagnosis and during follow-up. We compared the various ophthalmic findings in the different CDG subgroups.
Results:
Of the 45 patients, 22 had CDG type Ia, nine had CDG type Ic and 14 had a so-far undiagnosed biochemical background (CDG type Ix). We found ocular anomalies in 28 of the 45 children. Three had unique findings, including congenital cataract, retinal coloboma and glaucoma. A few CDG type Ia patients showed a sequential occurrence of symptoms, including retinitis pigmentosa or cataract.
Conclusions:
Ophthalmic findings are frequent in CDG syndrome involving both the anterior and posterior segment of the eye. The disorder might lead to abnormal development of the lens or the retina, cause diminished vision, alter ocular motility and intraocular pressure. We suggest routine screening and follow-up for ophthalmological anomalies in all children diagnosed with CDG syndrome to provide early treatment and adequate counselling.
Related Concept Videos
Proteoglycans
Photoreceptors and Visual Pathways
Inborn Errors of Metabolism
Glaucoma: Overview
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetic Retinopathy


